Recruiting studies: Adenovirus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Phase 1 · 7 location(s) · Akamis Bio · NCT06459869 A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and W
Phase 1 · 3 location(s) · International AIDS Vaccine Initiative · NCT06617091 Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910 Third Party Viral Specific T-cells (VSTs)
Phase 2 · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02532452 Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC
Phase 1 · 1 location(s) · West China Hospital · NCT07565740 Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
Phase 1/Phase 2 · 2 location(s) · Catherine Bollard · NCT03594981 A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Phase 3 · 81 location(s) · SymBio Pharmaceuticals · NCT07387367 TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Phase 1 · 2 location(s) · Baylor College of Medicine · NCT04013802 Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798 Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03425526 Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378 Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus S
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05101213 Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)
Phase N/A · 21 location(s) · Tenaya Therapeutics · NCT06311708 A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
Phase 2 · 11 location(s) · SymBio Pharmaceuticals · NCT04706923 Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Ce
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT05664126 Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
Phase 1 · 1 location(s) · Tongji Hospital · NCT07359235 Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic H
Phase 1 · 1 location(s) · West China Hospital · NCT07625423 Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Beijing Neurosurgical Institute · NCT06585527 Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
Phase 3 · 33 location(s) · Tobias Feuchtinger · NCT04832607 Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675 Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab fo
EARLY_Phase 1 · 1 location(s) · Huashan Hospital · NCT07538128 H101 Plus TACE for r/m HNSCC
Phase 2 · 1 location(s) · West China Hospital · NCT07398664 Adenovirus (RGDCRAdCOX2F)
Phase 1 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06693986 Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Phase 2 · 10 location(s) · New York Medical College · NCT03266627 A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Phase 1 · 3 location(s) · Dispatch Biotherapeutics · NCT07544589 Viral Infections in Healthy and Immunocompromised Hosts
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306084 Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
Phase 1/Phase 2 · 9 location(s) · Ensoma · NCT06876363 Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03159364 Donor-Derived Viral Specific T-cells (VSTs)
Phase 1/Phase 2 · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02048332 Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Phase 2 · 67 location(s) · Synairgen Research Ltd. · NCT06999603

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.